Miao Zhang, MD, PhD
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
About Dr. Miao Zhang
I am a genitourinary pathologist with expertise in collaborating with clinical colleagues, translational and basic researchers. I have collaborated with MD Anderson investigators and assisted them by providing pathological support, sharing insight into their design of experiments, trouble shooting, result interpretation, interpreting clinical findings and correlating them with basic research results, and participated in manuscript writing and editing. My PhD training with a major in immunology enables me to have a thorough understanding of the basic and translational research aspects of Dr. Thomposon’s NIH R01 award grant entitled” targeting treatment-emergent, PD-L1-driven prostate cancer neuroendocrine lineage plasticity”. I have the background to serve as collaborator and support Dr. Patricia Troncoso in addressing the tissue needs and pathology expertise of the grant application.
Read More
Present Title & Affiliation
Primary Appointment
Professor, The Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2005 | The University of Chicago, Chicago, Illinois, US, Biomedical Science, Pathology, Ph.D |
| 2000 | Peking Union Medical College, Beijing, CN, MD |
| 1995 | Peking University, Beijing, CN, Biology, BS |
Postgraduate Training
| 2012-2013 | GU Pathology Fellowship, Genitourinary Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland |
| 2011-2012 | Surgical Pathology Fellowship, Surgical Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York |
| 2007-2011 | Clinical Residency, Pathology, New York University School of Medicine, New York, New York |
| 2005-2007 | Post Doctoral Training, Rheumatology, The University of Chicago, Chicago, Illinois |
Licenses & Certifications
| 2013 | Texas Medical License |
| 2011 | American Boards of Anatomic and Clinical Pathology |
| 2011 | Medical License |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019
Extramural Institutional Committee Activities
Member, GU Medical Oncology Chair Searching Committee, The University of Texas MD Anderson Cancer Center, 2024
Chair, GU Subcommittee at CAPA (Chinese American Pathologists Association), The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Cancer Network Adjunct Appointment Review Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, ITB Advisory Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Faculty Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, Surgical and Sub-specialty Fellow Conference Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, The GU Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present
Honors & Awards
| 2006 | Best Oral Presentation Award, University of Chicago, Cluster of Biomedical Science |
| 1996 - 2000 | Best Student Scholarship, Peking Union Medical College |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. ACC Pathological Classification and Risk Stratification. Invited. 9th Adrenal Cancer Symposium. Houston, TX, US.
- 2024. lmmunotherapy in Space and Time: The Tumor Microenvironment. TMC Collaborative Building. Houston, Texas, US.
- 2019. Bladder Lesion. Houston, TX, US.
- 2019. Mimickers of Prostate Cancer. The University of Texas Health Science Center at Houston, McGovern Medical School. Houston, TX, US.
- 2018. Adrenal Cortical Tumors. Houston, TX, US.
- 2017. Adenoid Cystic Carcinoma. Houston Society of Clinical Pathologists. Houston, TX, US.
- 2016. Genomic Characterization of Bladder Cancer Variants: mRNA platform. UT MD Anderson Cancer Center. Houston, TX, US.
Regional Presentations
- 2025. Urethral adenocarcinoma, an underdiagnosed/misdiagnosed entity. Invited. CAPA GU Education Committee Kickoff Meeting. Dallas, TX, US.
- 2024. Neuroendocrine Carcinoma of Prostate. Invited. CAPA GU education subcommittee annual meeting. Dallas, TX, US.
National Presentations
- 2025. Novel Targetable Biomarkers in Adrenocortical Carcinomas. Conference. United States and Canadian Academy of Pathology (USCAP) Annual Meeting. Boston, MA, US.
- 2025. Primary Adenocarcinoma of the Urethra: A Clinicopathologic Study of 48 Cases. Conference. United States and Canadian Academy of Pathology (USCAP) Annual Meeting. Boston, MA, US.
- 2018. PCF Update. Invited. AACR. Chicago, IL, US.
- 2017. Reporting of Non-Seminomatous Germ Cell Tumor of Testis in Treatment Era. Invited. USCAP. San Antonio, TX, US.
- 2017. Atypical Adrenal Adenoma. Invited. USCAP. San Antonio, TX, US.
- 2016. Oncocytic Adrenal Cortical Neoplasm, A Clinical and Pathological Study of 59 Cases. Invited. USCAP. Seattle, WA, US.
- 2016. BK Virus: Unveiling a Pathogen in 46 Autopsies of Allogenic Stem Cell Transplant Recipients. Invited. USCAP. Seattle, WA, US.
- 2015. Secondary malignancy involves kidney. Invited. USCAP. Boston, MA, US.
- 2015. Molecular subtypes of bladder cancer. Invited. USCAP. Boston, MA, US.
- 2015. Urethral Carcinoma. Invited. USCAP. Boston, MA, US.
- 2014. Metastatic renal cell carcinoma involving bladder. Invited. USCAP. San Diego, CA, US.
- 2013. Testicular Fibrothecoma: a report of 16 cases. Invited. USCAP. Baltimore, MD, US.
- 2013. Differences in Prostate Cancer Grade, Stage, and Location in Radical Prostatectomy Specimens from the United States and Japan. Invited. USCAP. Baltimore, MD, US.
- 2010. The expression of GPR 30, a G protein-coupled receptor, in prostate cancer. Invited. USCAP. Washington, DC, US.
- 2009. LEF1 in androgen-independent prostate cancer: regulation of AR expression, prostate cancer growth and invasion. Invited. USCAP. Boston, MA, US.
- 2006. BCR ubiquitinylation and BCR trafficking. Conference. University of Chicago. Chicago, IL, US.
- 2003. BCR coordinate MHC class II trafficking. Conference. University of Chicago. Chicago, IL, US.
International Presentations
- 2024. GU Tumors. Invited. Japanese Foundation for Cancer Research. Tokyo, JP.
- 2018. Clinicopathologic Factors Associated with Local Tumor Recurrence Following Partial Nephrectomy. Invited. USCAP. Vancouver, CA.
- 2018. Adrenal Cortical Carcinoma: A Micro-Satellite Instability High Tumor?. Invited. USCAP. Vancouver, CA.
- 2016. Primary Urethral Carcinoma of the Genitourinary Tract. Invited. 2nd Macedonian Congress of Pathology, Macedonian Association of Pathology. Ohrid, MK.
Formal Peers
- 2024. Neuroendocrine carcinoma of the prostate. Invited. Tokyo, JP.
- 2024. CAPA Weekly Educational Courses. Invited, US.
- 2023. Asian Pacific International Academy of Pathology (AP-IAP), Moderator. Invited, US.
- 2023. CAPA Weekly Educational Courses. Invited, US.
- 2022. IAP-Thailand Annual Meeting. Invited. Virtual Meeting, US.
- 2022. CAPA-Hangzhou GU Diagnostic Course. Invited, CN.
- 2022. Challenging Diagnostic Issues in Kidney Biopsies. Invited. Durham, NC, US.
- 2022. CAPA Weekly Educational Courses. Invited, US.
- 2021. USCAP for GU Section, Moderator. Invited. Virtual Meeting, US.
- 2021. CAPA Weekly Educational Courses. Invited, US.
- 2020. Annual CAPA Diagnostic Course. Invited. Virtual Meeting, US.
- 2020. CAPA Weekly Educational Courses. Invited, US.
- 2019. CAPA Weekly Educational Courses. Invited, US.
- 2018. CAPA-Hangzhou GU Diagnostic Course. Invited, CN.
- 2018. Common and Challenging Issues in Diagnosing Kidney Pathology. Invited. Chicago, IL, US.
- 2018. Genitourinary Pathology. Invited. Philadelphia, PA, US.
- 2018. CAPA Weekly Educational Courses. Invited, US.
- 2017. Hot & Practical Topics in Diagnostic Pathology. Invited. Chicago, IL, US.
- 2017. Mimickers of Prostate Cancer. Invited. Beijing, CN.
- 2017. Annual CAPA Diagnostic Course. Invited. Chicago, IL, US.
- 2017. Urothelial Lesions with Inverted Growth. Invited. Beijing, CN.
- 2017. Prostate Cancer. Invited. Beijing, CN.
- 2017. Urothelial Lesions with Inverted Growth. Invited. Beijing, CN.
- 2017. CAPA Weekly Educational Courses. Invited, US.
- 2016. Invited Resident Teaching. Invited. Port Jefferson, NY, US.
- 2016. 2nd Macedonian Congress of Pathology. Invited, US.
- 2016. CAPA Weekly Educational Courses. Invited, US.
- 2003. BCR Trafficking. Invited. Keystone, CO, US.
Grant & Contract Support
| Date: | 2025 - 2030 |
| Title: | Obesity-linked drivers of prostate cancer subtypes |
| Funding Source: | NIH |
| Role: | Consult |
| ID: | 14349252 |
| Date: | 2025 - 2030 |
| Title: | The Role of KDM4A-H19 Axis in Neuroendocrine Prostate Cancer Metastasis |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | R01 CA307019-01 |
| Date: | 2025 - 2028 |
| Title: | Targetable DNA Damage Response pathways drive heterogeneity in patient outcomes to anti-androgen therapy in advanced hormone naïve prostate cancer |
| Funding Source: | DoD |
| Role: | Co-I |
| ID: | PC240628 |
| Date: | 2025 - 2023 |
| Title: | Comprehensive Clinical and Co-Clinical Characterization of Prostate Cancers Transitioning from Treatable to Lethal Phenotypes to Inform Individualized Treatment Strategy |
| Funding Source: | Prostate Cancer Foundation |
| Role: | Co-I |
| ID: | 2025TACT4985 |
| Date: | 2025 - 2027 |
| Title: | Targeting Hippo-YAP/TAZ signaling as novel strategy to overcome immunosuppressive TME in germ cell tumor |
| Funding Source: | DoD |
| Role: | Co-I |
| ID: | RA240510 |
| Date: | 2024 - 2029 |
| Title: | MD Anderson Cancer Center Prostate Cancer SPORE Core 2: Biospecimen and Pathology |
| Funding Source: | NIH/NCI |
| Role: | Core Co-Director |
| ID: | P50 CA288272 |
| Date: | 2024 - 2025 |
| Title: | SWOG NCTN BIQSFP Supplement for GY11 / SWOG Study S2312: Prospective Evaluation of Treatment Effect by the Aggressive Variant Prostate Cancer Molecular Signature (AVPC-MS) Assessed in an MDACC CLIA Certified Pathology Laboratory |
| Funding Source: | Oregon Health & Science University |
| Role: | PI |
| ID: | 3 U10 CA180888-11S1 |
| Date: | 2023 - 2026 |
| Title: | Development of stable, metastatic paraganglioma organoids to study evolution and drug response of aggressive tumors |
| Funding Source: | Paradifference Foundation |
| Role: | Collaborator |
| Date: | 2023 - 2028 |
| Title: | Revisiting Antiangiogenetic Therapy to Target Prostate Cancer Metabolism |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 CA275138-01A1 |
| Date: | 2022 - 2025 |
| Title: | Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression |
| Funding Source: | NCI |
| Role: | Other Significant Contributor |
| ID: | R01 CA276235-01 |
| Date: | 2022 - 2025 |
| Title: | PC210046P1: Revisiting Antiangiogenic Therapy to Target Prostate Cancer Metabolism |
| Funding Source: | Department of Defense (DOD) |
| Role: | Collaborator |
| ID: | FP00014476_Con2 |
| Date: | 2022 - 2026 |
| Title: | A Phase II trial single arm trial of Avelumab plus Cetuximab in advance cutaneous squamous cell carcinoma of the skin (cSCC) |
| Funding Source: | Alliance for Clinical Trials Onc Fndtn |
| Role: | PI |
| ID: | FP00008856_Con1 |
| Date: | 2022 - 2025 |
| Title: | Mechanisms and Therapies Focused on Epigenomic Alterations in Therapy-Resistant Prostate Cancers |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RP220410 |
| Date: | 2021 - 2024 |
| Title: | PC200420: Targeting Histone Lysine Demethylase KDM4A in Neuroendocrine Prostate Cancer |
| Funding Source: | Department of Defense (DOD) |
| Role: | Co-I |
| ID: | W81XWH-21-1-0522 |
| Date: | 2020 - 2025 |
| Title: | PC190353: Chemoimmunotherapy for Aggressive Variant Prostate Cancers (AVPC) |
| Funding Source: | Department of Defense (DOD) |
| Role: | Co-I |
| ID: | W81XWH-20-1-0257 |
| Date: | 2020 - 2025 |
| Title: | The role of histone lysine demethylase KDM4A in aggressive variant prostate cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | R01 CA244251 |
| Date: | 2019 - 2024 |
| Title: | The Role of Histone Demethylase KMD4A in Aggressive Variant Prostate Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 |
| Date: | 2018 - 2020 |
| Title: | Impact of Local Therapy on Outcomes of Men with de novo Metastatic (M1) Prostate Cancer (PCa) within Molecularly Defined Subsets |
| Funding Source: | Prostate Cancer Foundation |
| Role: | Co-I |
| ID: | 2017CHAL01 |
| Date: | 2014 - 2015 |
| Title: | Institutional Seed Grant |
| Funding Source: | UTMD Anderson Cancer Center |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Balderrama-Brondani, V, Marcal, LP, Moussa, MJ, Long, JP, Varghese, J, Waguespack, SG, Jimenez, C, Graham, PH, Fisher, SB, Perrier, ND, Shah, AY, Sheth, RA, Zhang, M, Campbell, M, Habra, MA. Circulating Tumor DNA Analysis in Adrenocortical Carcinoma. Endocrine Pathology 37(1), 2026. e-Pub 2026. PMID: 42467395.
- Corn, P, Yu, G, Fan, Y, Zhang, M, Troncoso, P, Surasi, DS, Liu, S, Ajani, JA, Logothetis, CJ, Wang, G, Panaretakis, T, Lin, S. Spatial immune profiling of bone-metastatic castration-resistant prostate cancer reveals radium-223 immunomodulates the bone-tumor microenvironment. Prostate Cancer and Prostatic Diseases 29(3):602-610, 2026. e-Pub 2026. PMID: 41454189.
- Chapin, BF, Smaldone, MC, Zurita-Saavedra, A, Wang, RJ, Cooperberg, MR, Gleave, ME, Delacroix, SE, Davis, JW, Pettaway, CA, Pisters, LL, Adibi, M, Chery, LJ, Papadopoulos, JN, Ward, JF, Gregg, JR, Navai, N, Corn, P, Subudhi, SK, Logothetis, CJ, Kuban, DA, Nguyen, Q, Tang, C, Choi, S, Hoffman, K, Lozano, M, Elsheftawi, M, Achim, M, Zhao, Y, Ramesh, N, Sei, E, Navin, N, Nogueras Gonzalez, G, Wang, X, Zhu, K, Troncoso, P, Zhang, M, McGuire, SE, Aparicio, A. A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer. European urology 90(2):125-136, 2026. e-Pub 2026. PMID: 41833492.
- Mak, SL, Zhu, M, Fu, J, Liang, X, Wang, X, Yuan, F, Wang, F, Hoang, A, Song, X, Shepherd, P, Liang, D, Suh, J, Contreras, J, Dang, T, Yan, C, Figueroa, B, Mazzocco, M, Luo, A, Pradhan, B, Park, J, Bashir, M, Zhang, M, Metzger, E, Schüle, R, Jain, A, Karasik, E, Frigo, DE, Foster, BA, Lee, MG, Corn, P, Logothetis, CJ, Aparicio, A, Navone, NM, Troncoso, P, Tan, Z, Zhang, J, Lin, S, Wang, G. KDM4A promotes NEPC progression through regulation of MYC expression. Cancer Letters 638, 2026. e-Pub 2026. PMID: 41319861.
- Zhang, M, Elsayes, KM, Guo, CC, Hansel, DE. Adrenocortical neoplasm with myxoid changes and pseudoglandular pattern. Human Pathology Reports 41, 2025. e-Pub 2025.
- Chan, Ys, Gao, Q, Robinson, SA, Wang, W, Filandrova, R, Weinhold, LM, Cabrera, ML, Zhang, M, Ambati, CR, Lerario, AM, Putluri, N, Kiseljak-Vassiliades, K, Wierman, ME, Habra, MA, Hammer, GD, Veverka, V, Cermakova, K, Courtney Hodges, H. β-catenin functions as a molecular adapter for disordered cBAF interactions. Molecular cell 85(16):3041-3056.e9, 2025. e-Pub 2025. PMID: 40695292.
- Zurita-Saavedra, A, Tidwell, R, Chapin, BF, Harris, DR, Zhang, M, Pisters, LL, Aparicio, A, Araujo, JC, Arce-Gallego, S, Zhu, K, Lozano, ML, Pagliaro, LC, Mateo, J, Logothetis, CJ, Troncoso, P, Davis, JW. Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis. European Urology Oncology 8(4):1010-1019, 2025. e-Pub 2025. PMID: 40651932.
- Zandberg DP, Allred JB, Rosenberg AJ, Kaczmar JM, Swiecicki P, Julian RA, Poklepovic AS, Bauman JR, Phan MD, Saba NF, Rivera E, Rowland K, Davar D, Cordes J, Ho AL, Zhang M, Berg SA, Munster PN, Schwartz GK. Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma. J Clin Oncol:JCO2500759, 2025. e-Pub 2025. PMID: 40448574.
- Nourbakshs M, Du L, Acosta AM, Alaghehbandan R, Amin A, Amin MB, Aron M, Berney D, Brimo F, Chan E, Cheng L, Colecchia M, Dhillon J, Downes MR, Evans AJ, Harik LR, Hassan O, Haider A, Humphrey PA, Jha S, Kandukuri S, Kao CS, Kaushal S, Khani F, Kryvenko ON, Kweldam C, Lal P, Lobo A, Maclean F, Magi-Galluzzi C, Mehra R, Miyamoto H, Mohanty SK, Montironi R, Nesi G, Netto GJ, Nguyen JK, Nourieh M, Osunkoya AO, Paner GP, Sangoi AR, Shah RB, Srigley JR, Tretiakova M, Troncoso P, Trpkov K, Van Der Kwast TH, Zhang M, Zynger DL, Williamson SR, Giannico GA. Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologists. Histopathology 87(2):206-222, 2025. e-Pub 2025. PMID: 40364451.
- Jackson, J, Sanchez, D, Joon, A, Estecio, MR, Johns, AC, Shah, AY, Campbell, M, Ward, JF, Pisters, LL, Guo, CC, Zhang, M, Millward, NZ, Tu, S. Bilateral Germ Cell Tumor of the Testis. Cells 14(9), 2025. e-Pub 2025. PMID: 40358182.
- MacDonald, LP, Jackson, JC, Lawen, TI, Kouzy, R, Colbert, L, Zhang M, Czerniak, BA, Pettaway, CA, Bree, KK. Urethral Adenocarcinoma: A Rare Malignancy With Poor Oncologic Outcomes Despite Neoadjuvant Treatment and Consolidative Therapy. JU Open Plus https://doi.org/DOI: 10.1097, 2025. e-Pub 2025.
- Serrano, A, Rocha, P, Freitas Lima, C, Stewart, A, Zhang, B, Diao, L, Fujimoto, J, Cardnell, R, Lu, W, Khan, KB, Sable, B, Ellison, AR, Wistuba, II, Concannon, KF, Halperin, DM, Czerniak, BA, Sircar, K, Zhang, M, Cargill, KR, Wang, Q, Aparicio, A, Lazar, A, Hernandez, S, Estrella, JS, Ramalingam, P, El-Naggar, AK, Kalhor, N, Gay, CM, Byers, LA, Solis Soto, LM. Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms. npj Precision Oncology 8(1), 2024. e-Pub 2024. PMID: 39558076.
- Myers, AA, Fang, A, Moussa, MJ, Hwang, H, Wilson, NR, Campbell, M, Msaouel, P, Lee, B, Guo, CC, Zhang, M, Zhao, J, Siefker-Radtke, AO, Kamat, A, Alhalabi, O. Impact of systemic therapy on clinical T1 small-cell neuroendocrine carcinoma of the bladder. ESMO Open 9(11), 2024. e-Pub 2024. PMID: 39471563.
- Yu G, Corn PG, Mak CSL, Liang X, Zhang M, Troncoso P, Song JH, Lin SC, Song X, Liu J, Zhang J, Logothetis CJ, Melancon MP, Panaretakis T, Wang G, Lin SH. Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt-pathway-induced M2 macrophage polarization. Proc Natl Acad Sci U S A 121(33):e2402903121, 2024. e-Pub 2024. PMID: 39102549.
- Hahn AW, Manyam GC, Chapin BF, Zhang M, Yu Y, Pettaway CA, Chery L, Pisters LL, Ward JF, Gregg JR, Papadopoulos J, Kamat AM, Lozano M, Hoang A, Broom B, Wang X, Huff CD, Logothetis CJ, Troncoso P, Pilié PG, Davis JW. A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates. BJU Int. e-Pub 2024. PMID: 38837608.
- Cho WC, Saade R, Nagarajan P, Aung PP, Milton DR, Marques-Piubelli ML, Hudgens C, Ledesma D, Nelson K, Ivan D, Zhang M, Torres-Cabala CA, Campbell M, Alhalabi O, Prieto VG, Wistuba II, Esmaeli B, Curry JL. Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin. J Cutan Pathol 51(5):360-367, 2024. e-Pub 2024. PMID: 38200650.
- Campbell MT, Balderrama-Brondani V, Jimenez C, Tamsen G, Marcal LP, Varghese J, Shah AY, Long JP, Zhang M, Ochieng J, Haymaker C, Habra MA. Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial. Lancet Oncol 25(5):649-657, 2024. e-Pub 2024. PMID: 38608694.
- Aparicio AM, Tidwell RSS, Yadav SS, Chen JS, Zhang M, Liu J, Guo S, Pilie PG, Yu Y, Song X, Vundavilli H, Jindal S, Zhu K, Viscuse PV, Lebenthal JM, Hahn AW, Soundararajan R, Corn PG, Zurita AJ, Subudhi SK, Zhang J, Wang W, Huff C, Troncoso P, Allison JP, Sharma P, Logothetis CJ. A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. e-Pub 2024. PMID: 38683200.
- Gregg JR, Magill R, Fang AM, Chapin BF, Davis JW, Adibi M, Chéry L, Papadopoulos J, Pettaway C, Pisters L, Ward JF, Hahn AW, Daniel CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso P. The association of body mass index with tumor aggression among men undergoing radical prostatectomy. Urol Oncol 42(4):116.e1-116.e7, 2024. e-Pub 2024. PMID: 38262868.
- Yu G, Corn PG, Mak CSL, Liang X, Zhang M, Troncoso P, Song JH, Lin SC, Song X, Liu J, Zhang J, Logothetis CJ, Melancon MP, Panaretakis T, Wang G, Lin SH. Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment. bioRxiv, 2023. e-Pub 2023. PMID: 38076845.
- Viscuse PV, Slack-Tidwell RS, Zhang M, Rohra P, Zhu K, San Lucas FA, Konnick E, Pilie PG, Siddiqui B, Logothetis CJ, Corn P, Subudhi SK, Pritchard CC, Soundararajan R, Aparicio A. Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments. Cancers (Basel) 15(24), 2023. e-Pub 2023. PMID: 38136389.
- Jimenez C, Ma J, Roman Gonzalez A, Varghese J, Zhang M, Perrier N, Habra MA, Graham P, Waguespack SG. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab 108(5):1132-1142, 2023. e-Pub 2023. PMID: 36433823.
- Alhalabi O, Zhu Y, Hamza A, Qiao W, Lin Y, Wang RM, Shah AY, Campbell MT, Holla V, Kamat A, Wang WL, Wang J, Chen J, Meng J, Zhang M, Bondaruk J, Titus M, Genovese G, Czerniak BA, Shaw KR, Meric-Bernstam F, Guo CC, Logothetis CJ, Siefker-Radtke A, Msaouel P, Wang L, Liu J, Gao J. Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer. Eur Urol Oncol 6(2):228-232, 2023. e-Pub 2023. PMID: 34789422.
- Baraban E, Ding CC, White M, Vohra P, Simko J, Boyle K, Guo C, Zhang M, Dobs A, Ketheeswaran S, Liang F, Epstein JI. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy. Am J Surg Pathol 46(12):1650-1658, 2022. e-Pub 2022. PMID: 36006769.
- Shirali AS, Zagzag J, Chiang YJ, Huang H, Zhang M, Habra MA, Grubbs EG, Fisher SB, Perrier ND, Lee JE, Graham PH. Differences in Clinicopathologic Behavior of Oncocytic Adrenocortical Neoplasms and Conventional Adrenocortical Carcinomas. Ann Surg Oncol 29(9):5555-5563, 2022. e-Pub 2022. PMID: 35499784.
- Sakellakis MJ, Hahn AW, Ramachandran S, Zhang M, Hoang A, Song JH, Liu J, Wang F, Basu HS, Sheperd P, Wang X, Frigo DE, Lin SH, Panaretakis T, Zhang J, Navone N, Troncoso P, Logothetis CJ, Titus MA. Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones. Prostate Cancer Prostatic Dis. e-Pub 2022. PMID: 36100698.
- Daher, M, Varghese, J, Gruschkus, SK, Jimenez, C, Waguespack, SG, Bedrose, S, Altameemi, L, Bazerbashi, H, Naing, A, Subbiah, V, Campbell, M, Shah, AY, Zhang, M, Sheth, RA, Karam, JA, Wood, CG, Perrier, ND, Graham, PH, Lee, JE, Habra, MA. Erratum to. Journal of Clinical Endocrinology and Metabolism 107(8):E3544, 2022. e-Pub 2022. PMID: 35536657.
- Ranasinghe, WK, Troncoso, P, Surasi, DS, Ibarra Rovira, JJ, Bhosale, PR, Szklaruk, J, Kokorovic, A, Wang, X, Elsheshtawi, MA, Zhang, M, Aparicio, A, Chapin, BF, Bathala, TK. Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI. Radiology 303(1):110-118, 2022. e-Pub 2022. PMID: 35076303.
- Daher M, Varghese J, Gruschkus SK, Jimenez C, Waguespack SG, Bedrose S, Altameemi L, Bazerbashi H, Naing A, Subaiah V, Campbell MT, Shah AY, Zhang M, Sheth RA, Karam JA, Wood CG, Perrier ND, Graham PH, Lee JE, Habra MA. Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience. J Clin Endocrinol Metab 107(5):1239-1246, 2022. e-Pub 2022. PMID: 35092681.
- Alhalabi O, Chen J, Zhang Y, Lu Y, Wang Q, Ramachandran S, Tidwell RS, Han G, Yan X, Meng J, Wang R, Hoang AG, Wang WL, Song J, Lopez L, Andreev-Drakhlin A, Siefker-Radtke A, Zhang X, Benedict WF, Shah AY, Wang J, Msaouel P, Zhang M, Guo CC, Czerniak B, Behrens C, Soto L, Papadimitrakopoulou V, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee J, Roth J, Swisher S, Wistuba I, Heymach J, Wang J, Campbell MT, Efstathiou E, Titus M, Logothetis CJ, Ho TH, Zhang J, Wang L, Gao J. MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers. Nat Commun 13(1):1797, 2022. e-Pub 2022. PMID: 35379845.
- Moore JA, Slack RS, Lehner MJ, Campbell MT, Shah AY, Zhang M, Guo CC, Ward JF, Karam JA, Wood CG, Pisters LL, Tu SM. Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and Implications. Cancers (Basel) 14(5), 2022. e-Pub 2022. PMID: 35267435.
- Hwang MJ, Hamza A, Zhang M, Tu SM, Pisters LL, Czerniak B, Guo CC. Somatic-type Malignancies in Testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases. Am J Surg Pathol 46(1):11-17, 2022. e-Pub 2022. PMID: 34334690.
- Ranasinghe WKB, Troncoso P, Surasi DS, Ibarra Rovira JJ, Bhosale P, Szklarus J, Kokorovic A, Wang X, Elsheshtawi M, Zhang M, Aparicio A, Chapin BF, Bathala TK. Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI. Radiology 303(1), 2022. e-Pub 2022.
- Guccione J, Soliman M, Zhang M, Habra MA, Collins K, Zhao J, Elsayes KM. Imaging characteristics of pathologically proven adrenal adenomas with myelolipomatous degeneration: correlation with clinical and pathologic features. Br J Radiol 95(1129):20210555, 2022. e-Pub 2022. PMID: 34623887.
- Liu Z, Ma J, Jimenez C, Zhang M. Pheochromocytoma: A Clinicopathologic and Molecular Study of 390 Cases From a Single Center. Am J Surg Pathol 45(9):1155-1165, 2021. e-Pub 2021. PMID: 34280940.
- Tu SM, Zhang M, Wood CG, Pisters LL. Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity. Cancers (Basel) 13(16), 2021. e-Pub 2021. PMID: 34439162.
- Collins K, Oramas DM, Guccione J, Elsayes KM, Habra MA, Zhang M, Cheng L. Incidentally discovered myelolipomatous adrenal adenomas, including six cases presenting with hypercortisolism. Pathol Res Pract 224:153508, 2021. e-Pub 2021. PMID: 34119816.
- Ranasinghe W, Shapiro DD, Zhang M, Bathala T, Navone N, Thompson TC, Broom B, Aparicio A, Tu SM, Tang C, Davis JW, Pisters L, Chapin BF. Optimizing the diagnosis and management of ductal prostate cancer. Nat Rev Urol 18(6):337-358, 2021. e-Pub 2021. PMID: 33824525.
- Umbreit EC, Siddiqui BA, Hwang MJ, Joon AY, Maity T, Westerman ME, Merriman KW, Alhasson H, Uthup J, Guo T, Moore JA, Ward JF, Karam JA, Wood CG, Pisters LL, Zhang M, Tu SM. Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor. Cancers (Basel) 12(12), 2020. e-Pub 2020. PMID: 33327406.
- Liu Z, Jimenez C, Wood C, Zhang M. A case of juxtaglomerular cell tumor with an unusual clinical presentation. Human Pathology: Case Reports 22, 2020. e-Pub 2020.
- Warmke L, Vining D, Ward III J, Troncoso P, Lin M, Ro J, Zhang M. Paratesticular clear cell carcinoma of müllerian origin—A case report. Human Pathology: Case Reports 21, 2020. e-Pub 2020.
- Guo CC, Bondaruk J, Yao H, Wang Z, Zhang L, Lee S, Lee JG, Cogdell D, Zhang M, Yang G, Dadhania V, Choi W, Wei P, Gao J, Theodorescu D, Logothetis C, Dinney C, Kimmel M, Weinstein JN, McConkey DJ, Czerniak B. Assessment of Luminal and Basal Phenotypes in Bladder Cancer. Sci Rep 10(1):9743, 2020. e-Pub 2020. PMID: 32546765.
- Corn PG, Zhang M, Nogueras-Gonzalez GM, Xiao L, Zurita AJ, Subudhi SK, Tu SM, Aparicio AM, Coarfa C, Rajapakshe K, Huang S, Navone NM, Lin SH, Wang G, Ramachandran S, Titus MA, Panaretakis T, Gallick GE, Efstathiou E, Troncoso P, Logothetis C. A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer. Clin Cancer Res 26(5):990-999, 2020. e-Pub 2020. PMID: 31941830.
- Siddiqui BA, Zhang M, Pisters LL, Tu SM. Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment. Transl Androl Urol 9(Suppl 1):S56-S65, 2020. e-Pub 2020. PMID: 32055486.
- Elsherif SB, Javadi S, Blair KJ, Morshid AI, Hui L, Khalaf AM, Elbanan MG, Zhang M, Habra MA, Elsayes KM. Preresection Radiologic Assessment and Imaging Features of 156 Pathologically Proven Adrenal Adenomas. J Comput Assist Tomogr 44(3):419-425, 2020. e-Pub 2020. PMID: 32345808.
- Gan Q, Joseph CT, Guo M, Zhang, M, Sun X, Gong Y. Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears. American Journal of Clinical Pathology. e-Pub 2019. PMID: 31175351.
- Sinha KM, Bagheri-Yarmand R, Lahiri S, Lu Y, Zhang M, Amra S, Rizvi Y, Wan X, Navone N, Ozpolat B, Logothetis C, Gagel RF, Huard J. Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer. Oncogene 38(25):5038-5049, 2019. e-Pub 2019. PMID: 30858546.
- Guo CC, Majewski T, Zhang L, Yao H, Bondaruk J, Wang Y, Zhang S, Wang Z, Lee JG, Lee S, Cogdell D, Zhang, M, Wei P, Grossman HB, Kamat A, Duplisea JJ, Ferguson JE, Huang H, Dadhania V, Gao J, Dinney C, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer. Cell Rep 27(6):1781-1793.e4, 2019. e-Pub 2019. PMID: 31067463.
- Wang G, Xiao L, Zhang, M, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC. Small cell carcinoma of the urinary bladder: a Clinicopathologic and Immunohistochemical analysis of 81 cases. Hum Pathol 79:57-65, 2018. e-Pub 2018. PMID: 29763719.
- Li R, Zhang, M, Duplisea JJ, Troncoso P, Ward JF. Detection and Treatment of Primary Prostatic Melanoma. Urology. e-Pub 2018. PMID: 30195014.
- Virarkar M, de Castro Faria S, Patnana M, Zhang, M, Sagebiel T. Leiomyoma of the Prostate: Case Report and Review of the Literature. Clin Genitourin Cancer 16(4):e771-e776, 2018. e-Pub 2018. PMID: 29483044.
- Chahoud J, Zhang, M, Pisters LL, Lin SC, Lin SH, Tu SM. Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors. Clin Genitourin Cancer. e-Pub 2018. PMID: 29807831.
- Chahoud J, Zhang, M, Shah A, Lin SH, Pisters LL, Tu SM. Managing seminomatous and nonseminomatous germ cell tumors. Curr Opin Oncol 30(3):181-188, 2018. e-Pub 2018. PMID: 29538040.
- Wood EL, Adibi M, Qiao W, Brandt J, Zhang, M, Tamboli P, Matin SF, Wood CG, Karam JA. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses. J Urol 199(2):393-400, 2018. e-Pub 2018. PMID: 28941919.
- Zhang, M, Adeniran AJ, Vikram R, Tamboli P, Pettaway C, Bondaruk J, Liu J, Baggerly K, Czerniak B. Carcinoma of the urethra. Hum Pathol 72:35-44, 2018. e-Pub 2018. PMID: 28827100.
- Skala SL, Xiao H, Udager AM, Dhanasekaran SM, Shukla S, Zhang Y, Landau C, Shao L, Roulston D, Wang L, Siddiqui J, Cao X, Magi-Galluzzi C, Zhang, M, Osunkoya AO, Smith SC, McKenney JK, Betz BL, Myers JL, Chinnaiyan AM, Tomlins SA, Mehra R. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays. Mod Pathol 31(1):179-197, 2018. e-Pub 2018. PMID: 28840857.
- Lotan TL, Torres A, Zhang, M, Tosoian JJ, Guedes LB, Fedor H, Hicks J, Ewing CM, Isaacs SD, Johng D, De Marzo AM, Isaacs WB. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers. Oncotarget 8(14):22772-22782, 2017. e-Pub 2017. PMID: 28186998.
- Fox MD, Xiao L, Zhang, M, Kamat AM, Siefker-Radtke A, Zhang L, Dinney CP, Czerniak B, Guo CC. Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases. Am J Clin Pathol. e-Pub 2017. PMID: 28371875.
- Msaouel P, Zhang, M, Tu SM. Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report. Clin Genitourin Cancer 15(1):e73-e77, 2017. e-Pub 2017. PMID: 27692813.
- Bilen MA, Hess KR, Campbell MT, Wang J, Broaddus RR, Karam JA, Ward JF, Wood CG, Choi SL, Rao P, Zhang, M, Naing A, General R, Cauley DH, Lin SH, Logothetis CJ, Pisters LL, Tu SM. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget 7(52):86283-86289, 2016. e-Pub 2016. PMID: 27861143.
- Zhang, M, Pettaway C, Vikram R, Tamboli P. Adenoid Cystic Carcinoma of the Urethra/Cowper's Gland with Concurrent High-Grade Prostatic Adenocarcinoma: A Detailed Clinico-Pathologic Case Report and Review of the Literature. Hum Pathol 58:138-144, 2016. e-Pub 2016. PMID: 27554206.
- Dadhania V, Zhang, M, Zhang L, Bondaruk J, Majewski T, Siefker-Radtke A, Guo CC, Dinney C, Cogdell DE, Zhang S, Lee S, Lee JG, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use. EBioMedicine 12:105-117, 2016. e-Pub 2016. PMID: 27612592.
- Huang H, Tamboli P, Karam JA, Vikram R, Zhang, M. Secondary malignancies diagnosed using kidney needle core biopsies: a clinical and pathological study of 75 cases. Hum Pathol 52:55-60, 2016. e-Pub 2016. PMID: 26980018.
- Liang L, Huang H, Dadhania V, Zhang J, Zhang, M, Liu J. Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases. Hum Pathol 51:96-102, 2016. e-Pub 2016. PMID: 27067787.
- Zhou C, Urbauer DL, Fellman BM, Tamboli P, Zhang, M, Matin SF, Wood CG, Karam JA. Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre. BJU Int 117(5):775-82, 2016. e-Pub 2016. PMID: 26053895.
- Zhang, M, Wah C, Epstein JI. Metastatic Renal Cell Carcinoma to the Urinary Bladder: A Report of 11 Cases. Am J Surg Pathol 38(11):1516-21, 2014. e-Pub 2014. PMID: 25140895.
- Takahashi H, Epstein JI, Wakui S, Yamamoto T, Furusato B, Zhang, M. Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan. Prostate 74(3):321-5, 2014. e-Pub 2014. PMID: 24259155.
- Zhang, M, Amberson JB, Epstein JI. Two Sequential Diagnoses of Atypical Foci Suspicious for Carcinoma on Prostate Biopsy: A Follow-up Study of 179 Cases. Urology 82(4):861-4, 2013. e-Pub 2013. PMID: 24074986.
- Zhang, M, Kao CS, Ulbright TM, Epstein JI. Testicular fibrothecoma: a morphologic and immunohistochemical study of 16 cases. Am J Surg Pathol 37(8):1208-14, 2013. e-Pub 2013. PMID: 23715159.
- Jain S, Singhal S, Francis F, Hajdu C, Wang JH, Suriawinata A, Wang YQ, Zhang, M, Weinshel EH, Francois F, Pei ZH, Lee P, Xu RL. Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma. World J Gastroenterol 17(35):3994-4000, 2011. e-Pub 2011. PMID: 22046087.
- Li Y, Wang L, Zhang, M, Melamed J, Liu X, Reiter R, Wei J, Peng Y, Zou X, Pellicer A, Garabedian MJ, Ferrari A, Lee P. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Res 69(8):3332-8, 2009. e-Pub 2009. PMID: 19351848.
- O'Neill SK, Veselits ML, Zhang, M, Labno C, Cao Y, Finnegan A, Uccellini M, Alegre ML, Cambier JC, Clark MR. Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells. Proc Natl Acad Sci U S A 106(15):6262-7, 2009. e-Pub 2009. PMID: 19332776.
- Zhang, M, Veselits M, O'Neill S, Hou P, Reddi AL, Berlin I, Ikeda M, Nash PD, Longnecker R, Band H, Clark MR. Ubiquitinylation of Ig beta dictates the endocytic fate of the B cell antigen receptor. J Immunol 179(7):4435-43, 2007. e-Pub 2007. PMID: 17878339.
- Hou P, Araujo E, Zhao T, Zhang, M, Massenburg D, Veselits M, Doyle C, Dinner AR, Clark MR. B cell antigen receptor signaling and internalization are mutually exclusive events. PLoS Biol 4(7):e200, 2006. e-Pub 2006. PMID: 16719564.
- Clark MR, Massenburg D, Siemasko K, Hou P, Zhang, M. B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway. Curr Opin Immunol 16(3):382-7, 2004. e-Pub 2004. PMID: 15134789.
- Clark MR, Massenburg D, Zhang, M, Siemasko K. Molecular mechanisms of B cell antigen receptor trafficking. Ann N Y Acad Sci 987:26-37, 2003. e-Pub 2003. PMID: 12727621.
Abstracts
- Xu P, Zhao Y, Yan Y, Ye R, Tang C, Sei E, Bai S, Tran T, Ruoff C, Ly C, Zhu K, Zhang M, Siddiqui B, Subudhi S, Corn P, Logothetis C, Troncoso P, Zurita-Saavedra A, Navin N. Co-evolution of cancer cells and their microenvironment of primary and lymph node metastatic prostate cancer under androgen deprivation therapy. American Association of Cancer Research (AACR) Annual Meeting 86(7):SI, 2026. e-Pub 2026.
- Zhang M, Vikram R, Sircar K, Troncoso P, Guo C, Tamboli P, Czerniak B. Primary Adenocarcinoma of the Urethra: A Clinicopathologic Study of 48 Cases. Laboratory Investigation; Annual Meeting of the United-States-and-Canadian-Academy-of- Pathology (USCAP), 2026. e-Pub 2026.
- Siddiqui B, Basu S, Jindal S, Zhang M, Zhu K, Troncoso P, Sandigursky S, Miller E, Skokos D, Moesta A, Mezzancello M, Seebach F, Lowy I, Tidwell R, Sharma P, Subudhi S. Hypervigilance: A phase Ib clinical trial to optimize risk-benefit of nezastomig (PSMAxCD28 costimulatory bispecific antibody) plus cemiplimab (anti-PD-1) in patients with metastatic castration-resistant prostate cancer (mCRPC). Clin Oncol; Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2026. e-Pub 2026.
- Zhang M, Zhu K, Kang H C, Logothetis C, Pilie P, Troncoso P. Towards the Development of Pathological Criteria of Early Resistance to Androgen Ablation in Sequential Prostate Biopsies. Laboratory Investigation; Annual Meeting of the United-States-and-Canadian-Academy-of- Pathology (USCAP), 2026. e-Pub 2026.
- Zhang M, Frank S, Vikram R, Troncoso P, Pettaway C, Tamboli P, Czerniak B. Post Radiation Adenocarcinoma of the Urethra: A Clinicopathologic Study of 10 Cases. Laboratory Investigation; Annual Meeting of the United-States-and-Canadian-Academy-of- Pathology (USCAP), 2026. e-Pub 2026.
- Pilie PG, Troncoso P, Zhang M. Integrating Tissue-Based Insights to Optimize ARPi+PARPi Therapy in Hormone Sensitive Prostate. 32nd Annual Prostate Cancer Foundation Scientific Retreat, 2025. e-Pub 2025.
- Subudhi SK, Siddiqui BA, Chapin BF, Basu S, Jindal S, Bataki E, Zhang M, Zhu K, Troncoso P, Sandigursky S, Miller E, Skokos D, Sims JS, Moesta A, Mezzancello M, Seebach F, Lowy I, Tidwell RS, Soule H, Allison J, Sharma P. A pilot presurgical trial of nezastomig (costimulatory PSMAxCD28 bispecific antibody) in patients with high-risk, localized prostate cancer followed by radical prostatectomy. 32nd Annual Prostate Cancer Foundation Scientific Retreat, 2025. e-Pub 2025.
- Siddiqui BA, Chapin BF, Basu S, Jindal S, Zhang M, Troncoso P, Zhu K, Martini L, Ravizzini G, Sandigursky S, Miller E, Skokos D, Sims J, Mezzancello M, Seebach F, Lowy I, Tidwell R S, Soule H, Sharma P, Subudhi S K. A pilot presurgical trial of nezastomig (REGN5678, PSMAxCD28) in patients with high-risk, localized prostate cancer followed by radical prostatectomy. The 2024 Prostate Cancer Foundation Annual Meeting, 2024. e-Pub 2024.
- Trikannad A, Vellanki S, Joon AY, Estecio MR, Johns AC, Campbell MT, Sanchez D, Ward JF, Pisters LL, Zhang M, Guo CC, Zacharias NM, Tu SM. Subsequent Malignant Neoplasms (SMN) in Patients with Germ Cell Tumor of the Testis (TGCT): Implications on a Genetic vs Stem Cell Origin of Cancers. European Society for Medical Oncology (ESMO), 2024. e-Pub 2024.
- Surasi DS, Bathala T, Choi S, Shah S, Nguyen QN, Hoffman K, Mayo L, Mok H, Frank S, Fang A, Sheth R, Hwang KP, Mawlawi O, Macapinlac H, Troncoso P, Zhang M, Pasyar S, Bassett R, Chapin B, Tang C. A Prospective Pilot Study Investigating 18F rhPSMA-7.3 PET/MRI to Detect Recurrent Disease and Guide Radiotherapy Planning in Patients with Biochemically Recurrent Prostate Cancer Post-Prostatectomy. American Society for Radiation Oncology (ASTRO) 2024(Abstract 64845):Session #QP 01, 2024. e-Pub 2024.
- Zheng L, Balderrama-Brondani V, Habra M, Zhang M. Intercellular adhesion molecule-1 (ICAM-1) expression in adrenal cortical carcinomas. 113th Annual Meeting of the United-States and- Canadian-Academy-of-Pathology (USCAP), 2024. e-Pub 2024.
- Siddiqui B, Chapin B, Basu S, Jindal S, Zhang M, Troncoso P, Zhu K, Sandigursky S, Miller E, Skokos D, Sims J, Mezzancello M, Seebach F, Lowy I, Tidwell R, Soule H, Sharma P, Subudhi S. A pilot presurgical trial of REGN5678 (Anti-PSMAxCD28) in patients with high-risk, localized prostate cancer followed by radical prostatectomy. 2024 SITC 39th Annual Meeting Abstract. Accepted(Abstract 646), 2024. e-Pub 2024.
- Tabet G, Zheng L, Zhang M. Quantitative Ki-67 in adrenal cortical lesions. 113th Annual Meeting of the United-States and- Canadian-Academy-of-Pathology (USCAP), 2024. e-Pub 2024.
- Mak, CSL, Zhu, M, Liang, X, Wang, F, Hoang, A, Song, X, Shepherd, P, Liang, D, Suh, J, Park, J, Zhang M, Metzger, E, Schule, R, Jain, A, Karasik, E, Foster, B, Lee, MG, Corn, P, Logothetis, CJ, Aparicio, A, Navone, N, Troncoso P, Zhang, JH, Lin, SH, Wang, G. KDM4A promotes NEPC progression through regulation of MYC expression. American Association of Cancer Research (AACR) Annual Meeting(Apr; 83(7)), 2023. e-Pub 2023.
- Williamson, S, Alaghehbandan, R, Amin, A, Amin, M, Aron, M, Brimo, F, Chan, E, Cheng, L, Colecchina, M, Dhillon J, Downes, M, Evans, A, Harik, L, Hassan, O, Haider, A, Humphrey, P, Jha, S, Kandukuri, S, Kao, CS, Kaushal, S, Khani, F, Kryvenko, O, Kweldam, C, Lal, P, Lobo, A, Maclean, F, Magi-Galluzzi, C, Mehra, R, Menon, S, Miyamoto, H, Mohanty, S, Montironi, R, Nesi, G, Netto, G, Nguyen, J, Nourieh, M, Osunkoya, A, Paner, G, Sangoi, A, Shah, R, Srigley, J, Tretiakova, M, Troncoso P, Trpkov, K, Kwast VD, T, Zhang M, Zynger D, Giannico G. Current Practices in Prostate Pathology Reporting: Results From A Survey of Genitourinary Pathologists. Mod Path; 112th Annual Meeting of the United-Statesand- Canadian-Academy-of-Pathology (USCAP) 103(3 (S826-S827 Abstract 242)), 2023. e-Pub 2023.
- Magill RG, Davis JW, Pettaway C, Pister L, Ward JF, Chapin BF, Papadopolous J, Adibi M, Chery L, Guerrero M, Zhang M, Troncoso P, Gregg JR. Association Of Body Mass Index With Tumor Zonal Origin And Pathologic Features At Radical Prostatectomy. Society of Urologic Oncology Meeting(San Diego, CA(Poster Presentation)), 2022. e-Pub 2022.
- Viscuse PV, Tidwell R, Liu JJ, Guo S, Vundavilli H, Zhang M, Subudhi SK, Zurita AJ, Corn PG, Tu SM, Araujo JC, Wang J, Efstathiou E, Wang JB, Pilie PG, Troncoso P, Zhnag JH, Wang WY, Logothetis C, Aparicio A. DynAMo: A dynamic allocation modular sequential trial of approved and promising therapies in men with metastatic CRPC. Clin Oncol; Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 40(Abstract 5059):Supplement S; Issue 16, 2022. e-Pub 2022.
- Pieretti AC, Kang HC, Choi H, Zhang M, Chapin BF, Ward JF, Troncoso P, Gregg JR. Role of MRI in defining focal therapy templates in patients with intermediate-risk prostate cancer. American Urological Association (AUA) Annual Meeting 207(Abstract MP55-03):E937- E937 Supplement S Issue 5, 2022. e-Pub 2022.
- Park PYS, Gao M, Wang X, Hwang H, Surasi DS, Anderson M, Ibarra JR, Javadi S, Morani A, Szklaruk J, Marcal L, Surabhi V, Bhosale P, Adibi M, Chapin BF, Chery LJ, Davis JW, Papadopoulos JN, Pettaway CA, Ward JF, Tang C, Choi S, Zhang M, Pisers L, Troncoso P, Bathala TK. Diagnostic performance of multiparametric MRI in the evaluation of ratio recurrent prostate cancer using the Prostate Imaging for Recurrence Reporting guidelines (PI-RR) and histopathologic correlation, 2022. e-Pub 2022.
- Ebare, K, Tu S, Zhang M. Bilateral Testicular Germ Cell Tumors in Post-Pubertal Males: Clinicopathologic Features and Important Prognostic Factors. Mod Path; 112th Annual Meeting of the United-Statesand- Canadian-Academy-of-Pathology (USCAP) 35(Abstract 548):599, 2022. e-Pub 2022.
- Zhang M, Aparicio A, Wang, XM, Chapin BF, Troncoso P. Aggressive Variant Prostate Cancer in Men with Hormone Naive, de novo Metastatic Prostate Cancer (M1PC). Laboratory Investigation; 111th Annual Meeting of the United-States-and-Canadian-Academy-of- Pathology (USCAP) 32(Abstract 1041), 2022. e-Pub 2022.
- Ebare K, Rodriguez J, Shehabeldin A, Marie Zacharias Milward N, Roberto Estecio M, Y Joon A, Shi-Ming T, Zhang M. DynAMo: A Dynamic Allocation Modular Sequential Trial of approved and promising therapies in men with metastatic CRPC, 2022. e-Pub 2022.
- Viscuse PV, Zhang M, Liu JJ, Tidwell R, Subudhi SK, Zurita AJ, Corn PG, Tu SM, Araujo, JC, Wang J, Efstathiou E, Wang JB, Pilie PG, Troncoso P, Zhang JH, Logothetis C, Aparicio A. Outcomes in men with metastatic castrate-resistant prostate cancer treated with early platinum-based chemotherapy following an unsatisfactory response to androgen receptor (AR) inhibition as part of the phase II dynamic allocation modular sequential (DynAMo) trial. J Clin Oncol; 110th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 39(Abstract 83), 2021. e-Pub 2021.
- Zhang M, Tu S, Hwang, M. Utility of Isochromosome 12p in Modern Treatment Era. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 33(Abstract 1042), 2020. e-Pub 2020.
- Liu Z, Jimenez C, Zhang M. Pheochromocytoma: Clinicopathological and molecular Study of 333 Cases. USCAP, 2020. e-Pub 2020.
- Viscuse PV, Zhang M, Liu JJ, Tidwell RS, Subudhi SK, Zurita AJ, Corn PG, Tu SM, Araujo JC, Wang J, Efstathiou E, Wang JB, Pilie PG, Troncoso P, Zhang JH, Logothetis C, Aparicio A. Linking the Aggressive Variant Prostate Cancer (AVPC) molecular signature (- ms) to androgen indifference in a prospective clinical trial. J Clin Oncol; Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 38(Abstract 156), 2020. e-Pub 2020.
- Vyas, S, Zhang M, Tu S. Origin of Germ Cell Tumors: Presence of Somatic Transformation and Role of Dedifferentiation in Mature Teratomas. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 33(Abstract 1030), 2020. e-Pub 2020.
- Zhang M, Aparicio A, Wang XM, Chapin BF, Troncoso P. Aggressive Variant Prostate Cancer in Men with Hormone Naive, de novo Metastatic Prostate Cancer (M1PC). Mod Pathol; 109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 33(Abstract 1041), 2020. e-Pub 2020.
- Kojima Y, Sircar K, Habra M, Zhang M. Biomarker Profiles in Adrenal Cortical Carcinomas. USCAP, 2019. e-Pub 2019.
- Zhang M, Aparicio A, Chapin BF, Troncoso P. Morphological and Molecular Characterization of Prospectively and Sequentially Analyzed Prostate Tumors from Men with Castration Sensitive, de novo Metastatic Prostate Cancer (M1PCa). Mod Pathol; 108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 32(Abstract 990), 2019. e-Pub 2019.
- Kojima Y, Zhang M, Hruska C, Tamboli P. Are We Under Staging Clear Cell Renal Cell Carcinomas?. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 32(Abstract 881), 2019. e-Pub 2019.
- Aparicio A, Zhang M, Ramesh N, Wang XM, Corn PG, Zurita AJ, Amado J, Davis JW, Pettaway CA, Adibi M, Mcguire SE, Tu SM, Wang J, Subudhi SK, Elsheshtawi MA, Efstathiou E, Logothetis C, Navin N, Troncoso P, Chapin BF. Aggressive variant prostate cancer (AVPC) molecular signature in castration-sensitive, de novo metastatic prostate cancer (M1PCa). Clin Oncol; Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 37(Abstract 5052), 2019. e-Pub 2019.
- Chahoud J, Zhang M, Lin S, Lin S, Tu S. Glypican 3 (GPC3) expression in a lethal subgroup of refractory cisplatin-resistant testicular germ cell tumor (TGCT). Clin Oncol; Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 36(Abstract 559), 2018. e-Pub 2018.
- Kojima Y, Hruska C, Sircar K, Habra M, Mouhammed H, Zhang M. Adrenal cortical carcinomas: A microsatellite instability-high tumor?. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 31(Abstract 993), 2018. e-Pub 2018.
- Hruska C, Wang G, Tamboli P, Petros FG, Wood CG, Matin SF, Zhang M. Local Tumor Recurrence Following Partial Nepherectomy. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 31(Abstract 972), 2018. e-Pub 2018.
- Hui L, Gamal EM, Elsayes KM, Zhang M. Atypical Adrenal Adenomas: A Radiological and Pathological Study of 159 Cases. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Abstract 938), 2017. e-Pub 2017.
- Zhang M, Samra H, Tu SM, Tamboli P. Percentage of Germ Cell Tumor Components in NonSeminomatous Germ Cell Tumor: Clinical Significance in Current Treatment Era. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Abstract 1087), 2017. e-Pub 2017.
- Wang G, Xiao L, Zhang M, Czerniak B, Guo C. Small Cell Carcinoma of the Urinary Bladder: A Clinicopathologic Analysis of 81 Cases. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Abstract 1071), 2017. e-Pub 2017.
- Dadhania V, Zhang M, Zhang L, Bondaruk J, Majewski T, Siefker-Radtke A, Guo C, Dinney C, Cogdell DE, Zhang S, Lee S, Lee JG, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Molecular Characterization of Luminal and Basal Subtypes of Bladder Cancer. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Abstract 883), 2017. e-Pub 2017.
- Zhang M, Samra H, Tu SM, Tamboli P. Malignant Mixed Germ Cell Tumor. USCAP, 2017. e-Pub 2017.
- Chahoud J, Zhang M, Lin SC, Lin SH, Tu SM. Intratumoral Heterogenity and Chemoresistance in NonSeminomatous Germ Cell Tumors. ASCO, 2017. e-Pub 2017.
- Bilen MA, Hess KR, Campbell MT, Wang J, Broaddus R, Karam JA, Ward JF, Wood CG, Rao P, Zhang M, General R, Cauley DH, Lin S, Pisters LL, Tu S. Intratumoral Heterogenity and Chemoresistance in NonSeminomatous Germ Cell Tumors. J Clin Oncol; Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 34(Abstract e16055), 2016. e-Pub 2016.
- Rao P, Naovarat B, Guo CC, Sircar K, Zhang M, Khalil F, Hernandez M, Tamboli P, Pettaway CA, Spiess PE, Dhillon J. Inter-Observer Variability among Urologic Pathologists in the Grading of Penile Squamous Cell Carcinoma. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 29(Abstract 1022), 2016. e-Pub 2016.
- Dadhania V, Guo C, Zhang M, Zhang L, Majewski T, Zhang L, Bondaruk, Zhang S, Choi W, McConkey D, Dinney C, Baggerly K, Bogdan C. Molecular Subtypes of Bladder Cancer and Their Signature Markers in Multi-Institutional Cohorts. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 29(Abstract 891), 2016. e-Pub 2016.
- Friedman K, Pai R, Glass WF, Shapall E, Rezvani K, Abudayyeh A, Zhang M. BK Virus: Unveiling a Pathogen in 46 Autopsies of Allogeneic Stem Cell Transplant Recipients. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 29(Abstract 912), 2016. e-Pub 2016.
- Huang H, Rao P, Sircar K, Habra M, Zhang, M. Oncocytic Adrenal Cortical Neoplasm, a Clinical and Pathological Study of 39 Cases. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 29(Abstract 951), 2016. e-Pub 2016.
- Huang H, Karam JA, Vikram R, Tamboli P, Zhang M. Secondary Malignancies in Kidney Biopsies: A Clinical and Pathological Study of 73 Cases. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 28(Abstract 914), 2015. e-Pub 2015.
- Zhang M, Guo C, Majewski T, Dadhania V, Sykulski M, Wronowska W, Choi W, McConkey D, Dinney C, Gambin A, Czerniak BA. Immunohistochemical Profiles of Molecular Subtypes of Bladder Cancer. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 28(Abstract 1078), 2015. e-Pub 2015.
- Zhang M, Adeniran AJ, Pettaway CA, Czerniak BA, Tamboli P. Primary Carcinomas of the Urethra: A Clinical and Pathological Analysis of 119 Cases. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 28(Abstract 1079), 2015. e-Pub 2015.
- Zhang M, Cheuk W, Epstein JI. Metastatic Renal Cell Carcinoma (RCC) to the Urinary Bladder: A Report of 11 Cases. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 27(Abstract 1123), 2014. e-Pub 2014.
- Zhang M, Kao C, Ulbright T, Epstein JI. Testicular Fibrothecoma: a report of 16 cases. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 26(Abstract 1087), 2013. e-Pub 2013.
- Zhang M, Lam HM, Yu MQ, Wang JH, Ouyang B, Jain S, Daniels G, Reuter V, Gopalan A, Osman I, Lee P, Ho SM. The Expression of GPR 30, a G Protein-Coupled Receptor, in Prostate Cancer. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 23(Abstract 1032), 2010. e-Pub 2010.
- Zhang M, Li YR, Wang LG, Melamed J, Liu XM, Wei JJ, Peng Y, Pellicer A, Garabedian MJ, Ferrari A, Lee P. LEF1 in androgen-independent prostate cancer: regulation of AR expression, prostate cancer growth and invasion. Mod Pathol; Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 22(Abstract 921), 2009. e-Pub 2009.
Book Chapters
- Zhang, M. Secondary tumors in the bladder, 141-145, 2021.
- Zhang, M. Testicular sex cord stromal tumors. In: Oncological Surgical Patholgy. Springer International Publishing, 2018.
- Zhang, M. Neuroendocrine carcinoma of the kidney. In: Kidney Cancer: Recent Advances in Surgical and Molecular Pathology. Springer International Publishing, 2018.
Patient Reviews
CV information above last modified September 09, 2026